Clinical Trials Browser

Completed × Interventional × Solid Tumor, Adult × Clear all

NCT04504942 2026-01-23

Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors

Phase 2 Completed

16 enrolled 16 charts

Other solid neoplasm

Solid Tumor, Adult

NCT05307874 2025-12-24

EVICTION-2

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT05582850 2025-08-28

EPRAD

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT02220556 2025-08-08

CTC-CEC-ADN

Phase NA Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03410121 2025-08-05

PACPAC-EPOC

Phase NA Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03990233 2025-06-26

A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT05620472 2025-04-09

Molecular Imaging of EpCAM Receptors Using [99mTc]Tc(CO)3-(HE)3-Ec1

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT04597541 2025-03-10

A Study of AK112 for Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT04020185 2024-12-11

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

Phase 1/2 Completed

40 enrolled 16 charts

Other solid neoplasm

Solid Tumor, Adult

NCT03516123 2024-09-19

A Study of CS3006 in Subjects with Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03523819 2024-09-19

A Study of CS1002 in Subjects with Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT05117177 2024-09-19

New Formulation Study of Inupadenant (EOS100850) in Patients with Cancer

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT04121442 2024-08-06

Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT05054348 2024-06-04

First-in-human Study of IO-108 as Single Agent and in Combination With a PD-1 Immune Check Point Inhibitor in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT05309187 2024-06-04

Dose-Escalation and Dose-Expansion Study of IO-202 and IO-202+Pembrolizumab in Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03728179 2024-02-20

RACIN

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT04683354 2023-02-13

Study of HL-085 in Patients With Advanced Solid Tumor Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03951116 2022-03-16

FCN-437c

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03673020 2021-12-02

Phase 1a Study to Evaluate Immunogenicity of ASV®

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03147378 2021-10-19

Food Effect Study of ModraDoc006 in Combination With Ritonavir

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03360734 2021-07-12

GATTO

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT04515043 2021-06-01

EXPLORATORY STUDY Addendum to INVAC1-CT-101 (NCT02301754)

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03017521 2021-04-22

K-BASKET, TAS-117, PI3K/AKT Gene Aberration

Phase 2 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03008018 2020-08-19

HDAC6i

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03081819 2019-09-11

A Phase I Study of SH003 for Evaluate Safe Dose Range in Patients With Solid Cancer

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT02717572 2019-04-05

18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03045003 2017-02-09

RESIL

Phase NA Completed

Other solid neoplasm

Solid Tumor, Adult